05/12/2021
6:21 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/11/2021
6:42 PM | BioMarin Pharmaceutical (Issuer)
Mueller Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2021
8:07 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2021
6:48 PM | BioMarin Pharmaceutical (Issuer)
MEIER RICHARD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2021
7:46 PM | BioMarin Pharmaceutical (Issuer)
Guyer Charles Greg (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/04/2021
7:27 PM | BioMarin Pharmaceutical (Issuer)
Davis George Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2021
7:24 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2021
1:10 PM | BioMarin Pharmaceutical (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/26/2021
7:44 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/20/2021
8:53 PM | BioMarin Pharmaceutical (Issuer)
Davis George Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
04/13/2021
3:31 PM | BioMarin Pharmaceutical (Filer)
| Form DEFA14A
| |
04/13/2021
3:30 PM | BioMarin Pharmaceutical (Filer)
| Form DEF 14A
| |
04/09/2021
4:57 PM | Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2021
6:35 PM | BioMarin Pharmaceutical (Issuer)
Mueller Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2021
1:17 PM | Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2021
4:45 PM | Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/23/2021
8:22 PM | BioMarin Pharmaceutical (Issuer)
Mueller Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/23/2021
8:12 PM | BioMarin Pharmaceutical (Issuer)
FUCHS HENRY J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/23/2021
8:00 PM | BioMarin Pharmaceutical (Issuer)
Davis George Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/23/2021
7:50 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/23/2021
7:40 PM | Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2021
8:01 PM | Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2021
8:42 PM | BioMarin Pharmaceutical (Issuer)
Guyer Charles Greg (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2021
8:39 PM | BioMarin Pharmaceutical (Issuer)
Mueller Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2021
8:35 PM | BioMarin Pharmaceutical (Issuer)
Davis George Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2021
8:31 PM | BioMarin Pharmaceutical (Issuer)
FUCHS HENRY J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2021
8:27 PM | Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2021
8:24 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2021
8:21 PM | Acosta Andrea (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2021
7:26 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/09/2021
4:59 PM | BioMarin Pharmaceutical (Issuer)
GREY MICHAEL G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2021
10:02 AM | BioMarin Pharmaceutical (Subject)
PRIMECAP MANAGEMENT CO/CA/ (Filed by)
| Form SC 13G/A
| |
02/26/2021
2:16 PM | BioMarin Pharmaceutical (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/25/2021
3:09 PM | BioMarin Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/22/2021
7:38 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2021
3:31 PM | BioMarin Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/19/2021
8:22 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2021
4:28 PM | BioMarin Pharmaceutical (Issuer)
Ho Maykin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2021
3:35 PM | BioMarin Pharmaceutical (Issuer)
Ho Maykin (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/18/2021
8:45 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2021
5:43 PM | BioMarin Pharmaceutical (Issuer)
LAWLIS V BRYAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2021
2:58 PM | BioMarin Pharmaceutical (Subject)
Capital Research Global Investors (Filed by)
| Form SC 13G/A
| |
02/12/2021
2:10 PM | BioMarin Pharmaceutical (Issuer)
Mueller Brian (Reporting)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
02/11/2021
8:35 PM | Acosta Andrea (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
02/11/2021
2:42 PM | BioMarin Pharmaceutical (Subject)
DODGE & COX (Filed by)
| Form SC 13G
| |
02/05/2021
7:03 AM | BioMarin Pharmaceutical (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A
| |
02/04/2021
6:48 PM | BioMarin Pharmaceutical (Issuer)
Mueller Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/01/2021
6:00 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/28/2021
6:35 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2021
8:56 AM | BioMarin Pharmaceutical (Subject)
PRIMECAP MANAGEMENT CO/CA/ (Filed by)
| Form SC 13G/A
| |
12/30/2020
7:02 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2020
3:30 PM | BioMarin Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2020
11:53 AM | BioMarin Pharmaceutical (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/05/2020
3:11 PM | BioMarin Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/15/2020
6:17 PM | Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/08/2020
7:35 PM | BioMarin Pharmaceutical (Issuer)
HERON ELAINE J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2020
11:00 AM | BioMarin Pharmaceutical (Subject)
PRIMECAP MANAGEMENT CO/CA/ (Filed by)
| Form SC 13G/A
| |
09/09/2020
10:20 AM | BioMarin Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/01/2020
8:44 PM | BioMarin Pharmaceutical (Issuer)
PYOTT DAVID E I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2020
5:56 PM | BioMarin Pharmaceutical (Issuer)
GREY MICHAEL G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/22/2020
8:15 PM | Acosta Andrea (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/22/2020
4:32 PM | BioMarin Pharmaceutical (Issuer)
FUCHS HENRY J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/21/2020
8:22 PM | Acosta Andrea (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/15/2020
8:32 PM | BioMarin Pharmaceutical (Issuer)
FUCHS HENRY J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2020
12:40 PM | BioMarin Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/30/2020
8:48 PM | BioMarin Pharmaceutical (Issuer)
Mueller Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/30/2020
1:11 PM | BioMarin Pharmaceutical (Issuer)
Dere Willard H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2020
6:24 PM | Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2020
5:04 PM | BioMarin Pharmaceutical (Issuer)
LAWLIS V BRYAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/01/2020
3:15 PM | BioMarin Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/29/2020
5:48 PM | BioMarin Pharmaceutical (Issuer)
Slamon Dennis (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2020
5:32 PM | BioMarin Pharmaceutical (Issuer)
PYOTT DAVID E I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2020
5:07 PM | BioMarin Pharmaceutical (Issuer)
MEIER RICHARD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2020
4:38 PM | BioMarin Pharmaceutical (Issuer)
LAWLIS V BRYAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2020
3:50 PM | BioMarin Pharmaceutical (Issuer)
HERON ELAINE J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2020
3:17 PM | BioMarin Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/12/2020
12:51 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2020
7:10 PM | BioMarin Pharmaceutical (Issuer)
Guyer Charles Greg (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2020
5:28 PM | BioMarin Pharmaceutical (Issuer)
Guyer Charles Greg (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/05/2020
6:22 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/04/2020
8:45 PM | BioMarin Pharmaceutical (Issuer)
Davis George Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2020
12:54 PM | BioMarin Pharmaceutical (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/29/2020
6:40 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/28/2020
1:37 PM | BioMarin Pharmaceutical (Issuer)
FUCHS HENRY J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/22/2020
4:15 PM | BioMarin Pharmaceutical (Issuer)
FUCHS HENRY J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/22/2020
8:00 AM | BioMarin Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/14/2020
3:15 PM | BioMarin Pharmaceutical (Filer)
| Form DEFA14A
| |
04/14/2020
3:15 PM | BioMarin Pharmaceutical (Filer)
| Form DEF 14A
| |
04/13/2020
5:24 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2020
6:58 PM | Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2020
7:54 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2020
7:39 PM | Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2020
7:34 PM | Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/24/2020
8:07 PM | BioMarin Pharmaceutical (Issuer)
Mueller Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/24/2020
7:57 PM | BAFFI ROBERT (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/24/2020
7:53 PM | BioMarin Pharmaceutical (Issuer)
Davis George Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/24/2020
7:48 PM | BioMarin Pharmaceutical (Issuer)
FUCHS HENRY J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/24/2020
7:42 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/24/2020
7:37 PM | Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2020
7:46 PM | BioMarin Pharmaceutical (Issuer)
LAWLIS V BRYAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
